Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
TCF Stock Chart & Stats
Day’s Range― - ―
52-Week Range0.20p - 1.25p
Previous CloseN/A
Volume87.69K
Average Volume (3M)2.47M
Market Cap
£4.79M
Enterprise Value1.98M
Total Cash (Recent Filing)£2.00M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Jun 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,129,622,300
10 Day Avg. Volume1,899,050
30 Day Avg. Volume2,470,289
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.44
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Evgen Pharma News
PremiumCompany Announcements
Theracryf PLC Announces Major Change in Voting Rights
PremiumCompany Announcements
Theracryf PLC Reports Change in Major Holdings
PremiumCompany Announcements
Theracryf PLC Sees Shift in Voting Rights
PremiumCompany Announcements
TheraCryf PLC Announces Change in Major HoldingsPremiumCompany Announcements
TheraCryf’s Chief Business Officer Increases Shareholding
PremiumCompany Announcements
Theracryf PLC Announces Change in Voting Rights
PremiumCompany Announcements
TheraCryf Raises £4.25 Million to Advance Drug Development
PremiumCompany Announcements
TheraCryf Appoints Dr. Alastair Smith as Non-executive Chair---
Options Prices
Currently, No data available
---
Ownership Overview
TCF FAQ
What was Evgen Pharma PLC’s price range in the past 12 months?
Evgen Pharma PLC lowest share price was 0.20p and its highest was 1.25p in the past 12 months.
What is Evgen Pharma PLC’s market cap?
Evgen Pharma PLC’s market cap is £4.79M.
When is Evgen Pharma PLC’s upcoming earnings report date?
Evgen Pharma PLC’s upcoming earnings report date is Jun 11, 2025 which is in 89 days.
How were Evgen Pharma PLC’s earnings last quarter?
Evgen Pharma PLC released its earnings results on Nov 28, 2024. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
Is Evgen Pharma PLC overvalued?
According to Wall Street analysts Evgen Pharma PLC’s price is currently Overvalued.
Does Evgen Pharma PLC pay dividends?
Evgen Pharma PLC does not currently pay dividends.
What is Evgen Pharma PLC’s EPS estimate?
Evgen Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Evgen Pharma PLC have?
Evgen Pharma PLC has 2,129,622,300 shares outstanding.
What happened to Evgen Pharma PLC’s price movement after its last earnings report?
Evgen Pharma PLC reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.818%.
Which hedge fund is a major shareholder of Evgen Pharma PLC?
Currently, no hedge funds are holding shares in GB:TCF
---
Company Description
Evgen Pharma PLC
Evgen Pharma (TCF) is a clinical-stage drug development company focused on the development of sulforaphane-based pharmaceuticals for the treatment of multiple diseases. The company operates in the biotechnology sector, utilizing its proprietary Sulforadex technology to stabilize and enhance the bioavailability of sulforaphane, a naturally occurring compound. Evgen Pharma's core products are centered around its lead compound, SFX-01, which is being investigated for use in cancer, neurological disorders, and other health conditions.
---
Technical Analysis
---